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ABSTRACT
Objective: In this investigation, the comparative hepatoprotective effect of aqueous and ethanolic extracts of Syzygium cumini (AESC and EESC, 
respectively) was studied on carbon tetrachloride (CCl4)-induced hepatic injury in rats. These findings were also compared with the standard 
hepatoprotective drug silymarin.
Methods: Hepatotoxicity was induced by a single dose of CCl4 to healthy Wistar rats. Standard drug (100 mg/kg) and test extracts (500 mg/kg for 
both) were given orally for 10 days; the effects were observed using different biochemical and histological methods.
Results: In most of the studied parameters test extracts exhibited significant hepatoprotection, these were comparative to standard. Histological 
analysis also revealed the protective nature of both the extracts.
Conclusion: These results suggest that the SC extracts can ameliorate CCl4 induced hepatic injury. However, its ethanolic extract was found to be 
relatively less effective than aqueous extract. Indicated, some hydrophilic active compound of SC might work here.
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INTRODUCTION
The liver is the principle organ which maintain body’s internal 
environment and control the metabolism of carbohydrate, protein, 
and fats [1]. It is also the primary site of almost all the biochemical 
pathways to growth, fight against disease, nutrient supply and storage, 
energy provision, detoxification, and reproduction [2,3]. Thus, to 
maintain a healthy liver is an essential factor for the overall health 
and well-being [4].
Hepatotoxicity means chemical-driven liver damage since liver cells 
are main site of detoxification and drug metabolism, certain toxin/
drug might injure the organ [3-5]. In addition, exposure of chemical 
agents which are used in laboratories and industries can also induce 
hepatotoxicity [6]. The previous investigations revealed that nearly 
40,000 deaths per year happened due different liver diseases [7].
The root cause of any chemical-induced toxicity is the generation of 
free radicals [4]. Carbon tetrachloride (CCl4) is a known pro-oxidative 
compound which has been extensively used to study liver injury 
induced by reactive oxygen species (ROS). The hepatotoxic effect of CCl4 
is considered to be initiated as a result of its reductive dehalogenation 
by cytochrome P4502E1, this produce highly reactive trichloromethyl 
radical (+CCl3), in the presence of oxygen +CCl3 further converted into 
a trichloromethyl peroxyl radical (+OOCCl3) [8]. These free radicals are 
highly reactive and may cause damages to tissue lipids and proteins [4,9]. 
In a number of reports, these free radicals have been reported to induce 
membrane lipid peroxidation and protein oxidation [7-9]. The more 
deleterious effects are on enzymatic system of the cells [9]. Activities 
of liver function enzymes such as alkaline phosphatase (ALP), serum 
glutamic oxaloacetic transaminase (SGOT), and serum glutamic pyruvic 
transaminase (SGPT) are also disturbed. These are well-recognized 
markers of tissue cirrhosis, necrosis, decreased functioning and 
abnormal metabolism, etc. [10,11].
Antioxidants are well-known protective agents which either inhibit 
generation of free radicals or by enhance their removal [7,9]. Thousands 
of herbs have been reported to have antioxidative property [6,10-12].
Although several allopathic drugs are available, number of reports 
also stated their detrimental side effects on body’s functioning [13]. 
Therefore, plant-based therapy is supposed to be more reliable [10]. 
Plant parts and their extracts are potential agents for the management 
and treatment of oxidative stress-induced diseases [11,13]. Because 
these medicines are not only economic and affordable but are also safer 
and are extensively using as effective medication [14]. The Syzygium 
cumini (SC) is a popular traditional medicinal plant, which exhibits 
tremendous pharmacological effect in different experimental works. 
For example, its stem bark is a rich source of eugenin, quercetin, 
kaempferol, bergenins, flavianoids, tannins, pentacyclic triterpenoid 
betulinic acid, ester of epifriedelanol, friedelin and β-sitosterol, 
etc. [15-17]. The known antioxidants such as gallic acid, ellagic acid, 
resin, etc. are also known to be present in the bark [18]. In different 
premedical and medical analysis, different parts of this plant have 
been known to show immunomodulatory, hypolipidemic, antidiabetic, 
antibacterial, and the inflammatory action [13,15]. However, reports on 
the hepatoprotective effects against oxidative injury are meagre.
As different active constituents have differential medicinal potencies 
so these can be extracted in different extraction medium [19]. In this 
investigation, the less studied hepatoprotective efficacy of ethanolic 
and aqueous extracts of SC (EESC and AESC) was studied in CCl4 
induced hepatotoxic rats. Enzymatic activity such as ALP, SGOT, and 
SGPT as well as serum total bilirubin (TBil) was taken as studied 
parameters. Silymarin a known hepatoprotective drug [10,19] also 
used as a standard to reveal the relative potency of the test extracts. 
Tissue histology was also done to confirm the results.
METHODS
Chemicals
All chemicals were of the highest commercially available purity. The 
bark of SC was collected from D-1 University Campus, Dewas Road, 
Ujjain, Madhya Pradesh, India. The identification of plant was done 
in Department of Botany, Safia College of Science, Bhopal (Madhya 
Pradesh) and the voucher specimen 438/Bot/saf/13, was deposited in 
the Safia College of Science, Bhopal (Madhya Pradesh).
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Preparation of extracts
To prepare the extract of SC bark, the cleaned and air-dried bark was 
ground to a coarse powder. The powdered bark was exhaustively 
extracted is in soxhlet extractor with ethanol. Removal of solvent under 
reduced pressure afforded solid mass. Ethanol extract was obtained in 
good amount. For the preparation of aqueous extract, the bark powder 
was oaked in distilled water in a flask for 24 hrs. After that, the solution 
was filtered by Whatman filter paper (no. 1) and the filtrate was 
collected. The residue was again soaked with 20 volume distilled water 
to get additional extractives. All the filtrates were collected in a round 
bottom flask. Gummy substance was obtained using vacuum rotary 
evaporator. Then, the substance was dried at room temperature. The 
powdered extract was stored at 40°C for further experiment.
Animals
Healthy inbred albino Wistar rats of either sex (2-2.5 months old) were 
housed in polypropylene cages under constant temperature (27±2°C) 
and photo schedule (14 hrs light and 10 hrs dark). They were provided 
rodent feed (Golden Feeds, New Delhi, India) ad libitum and had free 
access to boiled drinking water. The approval of departmental ethical 
committee for handling and maintenance for experimental animals was 
also obtained before starting the experiments.
Induction of hepatotoxicity
Hepatic injury was induced by single oral administration of CCl4 mixed 
with olive oil as vehicle in 1:1 ratio (3 ml/kg of rat body weight). Animals 
with hepatic injury were posttreated with silymarin and extracts.
Experimental design
In the experiment, a total of 30 rats were used, which were divided into 
five groups having six animals in each group as follows:
• Group I: Normal control rats received 1 ml/100 g of 0.5% per oral 
for 10 days
• Group II: Negative control rats received CCl4 3 ml/kg, p.o. only once 
a day 1
• Group III: Rats received CCl4 3 ml/kg, p.o. and Silymarin (100 mg/kg, 
p.o.) for next 10 days, designated as STAND group
• Group IV: Rats received CCl4 3 ml/kg, p.o. and AESC (500 mg/kg p.o.) 
once daily for 10 days, designated as AESC group
• Group V: Rats received CCl4 3 ml/kg, p.o. and EESC (500 mg/kg p.o.) 
once daily for 10 days, designated as EESC group.
At the end of the experiment on the 10th day, animals were kept on 
overnight fasting and blood was collected by orbital puncture method. 
This blood was then allowed to clot for 30 minutes at room temperature. 
The serum was separated by centrifugation at 3000 rpm at 30°C for 
15 minutes.
Biochemical estimation
The serum samples were analyzed spectrophotometrically for ALP, 
SGOT, SGPT, and TBil levels using standard kits (Span Diagnostics 
Ltd). The activity of SGOT and SGPT was measured at 505 nm and is 
expressed as IU/L of serum. In ALP assay, the blue color developed 
which was read at 510 nm against blank and the activity is expressed as 
IU/L of serum. To estimate the TBil readings were taken at 540 nm, the 
level of TBil was expressed as mg/dL of serum [20].
Histological study
Histopathological study was done using the protocol of Deepa and 
Varalakshmi [21]. Tissues were fixed in 10% formaldehyde and then 
dehydrated in descending grades of isopropanol, cleared in xylene, 
and then embedded in molten paraffin wax. These fixed tissues were 
subsequently cut into 5 µm thick sections using microtome. The ribbons 
were then stained with hematoxylin and eosin and viewed under light 
microscope to study histopathological changes.
Statistical analysis
Data are expressed as mean ± standard error. Statistical analysis was 
performed using one-way ANOVA followed by unpaired Student’s t-test 
and p-values of 5% and less were considered as significant.
Fig. 1: Effects of different extracts of Syzygium cumini (SC) 
on serum total bilirubin (TBIL) in experimental animals. 
Cont (Normal control), induced (carbon tetrachloride [CCl4] 
treated), STAND (CCl4+silymarin), aqueous extracts of SC (AESC) 
(CCl4+AESC), and ethanolic extracts of SC (EESC) (CCl4+EESC). 
Each bar represents, the mean±standard error (n=6), *p<0.001, 
as compared to normal control, ap<0.05 and bp<0.01 as compared 
to CCl4 treated group, and xp<0.05, yp<0.01, and zp<0.001 as 
compared to standard drug, whereas #p<0.05 than AESC group
Fig. 2: Effects of different extracts of Syzygium cumini (SC) on 
alkaline phosphatise (ALP) in experimental animals. Cont 
(Normal control), Induced (carbon tetrachloride [CCl4] treated), 
STAND (CCl4+silymarin), aqueous extract of SC (CCl4+AESC), and 
ethanolic extract of SC (CCl4+EESC). Each bar represents, the 
mean±standard error (n=6), *p<0.001, as compared to normal 
control, ap<0.05 and bp<0.01 as compared to CCl4 treated group, 
and xp<0.05, yp<0.01 and zp<0.001 as compared to standard drug, 
whereas #p<0.05 than AESC group
RESULTS AND DISCUSSION
As compared to normal control animals CCl4 induced animals showed 
significant increased values of serum ALP, SGOT, SGPT, and TBil 
(p<0.001, for all), as showed in Figs. 1-4. As already demonstrated 
earlier, here also treatment with standard drug significantly reduced, the 
values of all above mentioned parameters (p<0.05, p<0.001, p<0.0001, 
and p<0.001, respectively). AESC administration showed significant 
reduction in TBil (p<0.001), SGOT and SGPT (p<0.001, for both) than 
induced group but these values are significantly less effective than that 
of standard drug for SGPT (p<0.001) and SGOT (p<0.05). Treatment 
with EESC also found to be considerably effective, as it reduces the 
increased values of TBil (p<0.01), SGPT and SGOT (p<0.001, for both) 
than induced group. Comparative analysis showed that the treatment 
with EESC was found to less effective (p<0.05 or more) or ineffective 
than standard drug and AESC for some of the parameters. Histological 
analysis also revealed that the both the extracts showed less or more 
hepatoprotective activities (Fig. 5).
In this experiment, we found that the AESC has more hepatoprotective 
activity than EESC. In addition, their protective efficacy was also found 
to be comparable to that of standard drug used. Induction of oxidative 
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injury with the CCl4 treatment has already been reported earlier [6,8,9]. 
This is a characteristic system of the xenobiotic-induced hepatotoxicity 
and is a commonly used model for the screening of hepatoprotective 
activity [10,11].
Generation of excessive ROS may result in damaged plasma membrane, 
which unable the plasma membrane to resist the leakage of cytosolic 
proteins into the bloodstream [18,21]. Hence, their increased serum 
values are used as a useful quantitative marker of the extent and 
type of hepatocellular damage. The increased levels of SGOT, SGPT, 
ALP, and TBil in CCl4 induced rats interpreted as a result of the liver 
cell destruction or changes in the membrane permeability indicated 
severity of hepatocellular damage by CCl4 [8,10].
TBil measurement includes both unconjugated and conjugated 
bilirubin. Unconjugated bilirubin is a breakdown product of heme is 
mainly transported bound to albumin circulating in the blood [22]. The 
addition of high concentration hydrophobic drugs, chemicals, and high 
free fatty acids can cause elevated unconjugated bilirubin [23]. The 
liver is responsible for clearing the blood of unconjugated bilirubin 
by uridine 5’-diphospho-glucuronyl-transferase, and secreted into the 
bile by canalicular multispecific organic anion transporter 1 (multidrug 
resistance-associated protein 2); these are usually excreted into the 
intestine. However, in the case of hepatobiliary disease and severe 
disturbance of hepatocellular function, TBil level enchases [22,23]. The 
extracts mediated suppression of the increased bilirubin level caused 
by CCl4 suggests the possibility of the extracts being able to stabilize 
biliary dysfunction.
ALP is an active enzyme in the cells lining the biliary ducts of the liver 
and it’s increased level indicates large bile duct obstruction, intrahepatic 
cholestasis, or infiltrative diseases of the liver [13,17]. However, it’s 
elevated values in growing children and in the third trimester of 
pregnancy is normal. In this investigation, the SC extracts were seemed 
to be non-significantly effective for the activity of ALP. This might 
indicate that both AESC and EESC served via different mechanism [24].
Moreover, biliary tract disease produces relatively greater increases 
in ALP than increases in SGOT and SGPT. These two are another set of 
enzymes associated with liver parenchymal cells [22] and are elevated 
in acute liver damage, but is also present in red blood cells, and cardiac 
and skeletal muscle, so is not specific to the liver [25]. The rise in 
SGOT activity is almost due to hepatocellular damage and is usually 
accompanied by the rise in SGPT [22,23]. Here, treatment with the 
different extracts attenuated the increased activities of these enzymes 
in serum. Recovery toward the normalization suggests that these 
extracts caused parenchymal cell regeneration in liver, thus protecting 
membrane fragility and thereby decreasing enzyme leakage [25].
CONCLUSION
The present finding revealed that CCl4 induced hepatotoxic model 
indicated drastic elevated values of liver stress markers, which were 
observed to be recovered in both test extracts. In addition to this, 
probably hydrophilic ingredients of the SC were seemed to more 
protective than hydrophobic compound rich extracts. Since the effects 
were extract specific and also depend on the stress parameters used, so 
to know the exact mechanism of protective action of the used extracts 
further studied are needed.
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